Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Antilymphocyte Serum × Clear all

NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Phase 2 Withdrawn

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular